Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis Case report

被引:11
|
作者
Guppy, Kern H. [1 ]
Akins, Paul T. [1 ]
Moes, Gregory S. [1 ]
Prados, Michael D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurosurg, Kaiser Permanente Med Grp, Sacramento, CA 95825 USA
关键词
spinal cord oligodendroglioma; oligodendrogliomatosis; spinal cord tumor; 1p deletion; 19q deletion; cytogenetics; temozolomide; RAISED INTRACRANIAL-PRESSURE; ANAPLASTIC OLIGODENDROGLIOMA; LEPTOMENINGEAL OLIGODENDROGLIOMA; INTRAMEDULLARY OLIGODENDROGLIOMA; SURGICAL-MANAGEMENT; GLIOMATOSIS; TUMORS; DISSEMINATION; MENINGEAL; CHILDREN;
D O I
10.3171/2009.2.SPINE08853
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oligodendroglioma of the spinal cord is a rare tumor that most often presents with spinal cord symptoms. The authors present a case of spinal cord oligodendroglioma that was associated with cerebral rather than spinal cord symptoms. A 30-year-old woman developed nausea, vomiting, and severe headaches. Magnetic resonance imaging of the brain showed meningeal enhancement. The patient underwent a craniotomy with biopsies of the meninges and brain. The biopsy findings revealed an abnormal arachnoid thickening without tumor cells. The patient later developed hydrocephalus and underwent shunt placement. Cerebrospinal fluid cytological findings were negative for tumor cells or infection. She was found to have a cervical cord lesion at C3-4 that was initially nonenhancing but later enhanced after Gd administration. Biopsy of the cord lesion with partial resection showed a WHO Grade 11 oligodendroglioma with 1p and 19q deletions determined by fluorescence in situ hybridization. Neurooncological treatment with tumor radiation and temozolomide (Temodor) resulted in improvement in radiographic findings, symptoms, and long-term survival. This paper presents an extensive review of the literature, which revealed only 2 other reported cases of cerebral symptoms in adults that preceded spinal cord symptoms in a patient with oligodendroglioma of the spinal cord. It is also the first reported case of oligodendroglimatosis due to a cervical spinal cord oligodendroglioma with I p and 19q deletions. (DOI: 10.3171/2009.2.SPINE08853)
引用
收藏
页码:557 / 563
页数:7
相关论文
共 50 条
  • [41] An expanded role for surgery in grade 3 1p/19q co-deleted oligodendroglioma
    Gupta, Saksham
    Nawabi, Noah L.
    Emani, Siva
    Medeiros, Lila
    Bernstock, Joshua D.
    Duvall, Julia
    Ng, Patrick
    Smith, Timothy R.
    Wen, Patrick Y.
    Reardon, David A.
    Arnaout, Omar
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [42] Recurrent anaplastic oligodendroglioma with 1p/19q loss and a progressive increase in p53 immunoreactivity: Case study.
    Nathoo, N
    Commane, M
    Varma, A
    Chernova, OB
    Stevens, G
    Staugaitis, S
    Vogelbaum, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (05): : 539 - 539
  • [43] 1p and 19q FISH Study of the Glioblastomas
    Kim, B.
    Myung, J. K.
    Byun, S. J.
    Park, S. H.
    LABORATORY INVESTIGATION, 2009, 89 : 331A - 331A
  • [44] 1p and 19q FISH Study of the Glioblastomas
    Kim, B.
    Myung, J. K.
    Byun, S. J.
    Park, S. H.
    MODERN PATHOLOGY, 2009, 22 : 331A - 331A
  • [45] Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion andTP53mutation: a case report
    Ono, Takahiro
    Reinhardt, Annekathrin
    Takahashi, Masataka
    Nanjo, Hiroshi
    Kamataki, Akihisa
    von Deimling, Andreas
    Shimizu, Hiroaki
    ACTA NEUROCHIRURGICA, 2020, 162 (12) : 3019 - 3024
  • [46] Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report
    Hirokazu Takami
    Akitake Mukasa
    Shunsaku Takayanagi
    Tsukasa Koike
    Reiko Matsuura
    Masako Ikemura
    Tetsuo Ushiku
    Gakushi Yoshikawa
    Junji Shibahara
    Shota Tanaka
    Nobuhito Saito
    Brain Tumor Pathology, 2023, 40 : 26 - 34
  • [47] Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report
    Takami, Hirokazu
    Mukasa, Akitake
    Takayanagi, Shunsaku
    Koike, Tsukasa
    Matsuura, Reiko
    Ikemura, Masako
    Ushiku, Tetsuo
    Yoshikawa, Gakushi
    Shibahara, Junji
    Tanaka, Shota
    Saito, Nobuhito
    BRAIN TUMOR PATHOLOGY, 2023, 40 (01) : 26 - 34
  • [48] Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion and TP53 mutation: a case report
    Takahiro Ono
    Annekathrin Reinhardt
    Masataka Takahashi
    Hiroshi Nanjo
    Akihisa Kamataki
    Andreas von Deimling
    Hiroaki Shimizu
    Acta Neurochirurgica, 2020, 162 : 3019 - 3024
  • [49] Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells
    Wharton, S. B.
    Maltby, E.
    Jellinek, D. A.
    Levy, D.
    Atkey, N.
    Hibberd, S.
    Crimmins, D.
    Stoeber, K.
    Williams, G. H.
    ACTA NEUROPATHOLOGICA, 2007, 113 (02) : 119 - 127
  • [50] Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells
    S. B. Wharton
    E. Maltby
    D. A. Jellinek
    D. Levy
    N. Atkey
    S. Hibberd
    D. Crimmins
    K. Stoeber
    G. H. Williams
    Acta Neuropathologica, 2007, 113 : 119 - 127